![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al.; International Association for the Study of Obesity. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645.
- Azizah AM, Nor Saleha IT, Noor Hashimah A, et al. 2016. Malaysian national cancer registry report 2007–2011 malaysia cancer statistics. Data and Figure. National Cancer Institute, Ministry of Health; 71.
- Bjørge T, Engeland A, Tretli S, Weiderpass E. 2007. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. International Journal of Cancer 120:378–383.
- Bokhman JV. 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 15:10–17.
- Britton T, Nicolas W, Ashley SF, et al. 2015. Metabolic syndrome and risk of endometrial cancer in United States: a study in the SEER-Medicare linked database. Cancer Epidemiology, Biomarkers & Prevention 24:261–267.
- Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjønneland A, et al. 2007. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)). Endocrine-Related Cancer 14:755–767.
- Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Giugliano D, et al. 2014. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine 45:28–36.
- Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, et al. 2010. Factors associated with Type I and Type II endometrial cancer. Cancer Causes & Control: CCC 21:1851–1856.
- Friberg E, Orsini N, Mantzoros CS, Wolk A. 2007. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374.
- Friedenreich CM, Biel RK, Lau DCW, Csizmadi I, Courneya KS, Magliocco AM, et al. 2011. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer. Cancer Epidemiology Biomarkers & Prevention 20:2384–2395.
- Furberg AS, Thune I. 2003. Metabolic abnormalities (hypertension, hyperglycaemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. International Journal of Cancer 104:669–676.
- Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al.; International Agency for Research on Cancer Handbook Working Group. 2016. Body fatness and cancer-viewpoint of the IARC Working Group. The New England Journal of Medicine 375:794–798. (8):
- Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. 2008. Body mass, diabetes and smoking, and endometrial cancer risk: follow-up study. British Journal of Cancer 98:1582–1585.
- Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. 2009. Serum lipids and endometrial cancer risk: results from the HUNT-II study. International Journal of Cancer 124:2938–2941. 15
- Luo J, Beresford S, Chen C, Chlebowski R, Garcia L, Kuller L, et al. 2014. Association between diabetes, diabetes treatment and risk of developing endometrial cancer. British Journal of Cancer 111:1432–1439. 23
- Ni J, Zhu T, Zhao L, Che F, Chen Y, Shou H, et al. 2015. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 17:835–839.
- Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. 2008. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 371:569–578.
- Rosato V, Zucchetto A, Bosetti C, Dal Maso L, Montella M, Pelucchi C, et al. 2011. Metabolic syndrome and endometrial cancer risk. Annals of Oncology: Official Journal of the European Society for Medical Oncology 22:884–889.
- Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, et al. 2013. Type I and II endometrial cancers: have they different risk factors?. Journal of Clinical Oncology 10:2607–2618.
- Yan Z, Zhiwei L, Xinchun Y, Xiaofei Z, Shiming L, Xiaoduan C, Bingjian L. 2010. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynaecologic Oncology 117:41–46.